Stock GEHC GE HEALTHCARE TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
81.11 USD -0.39% Intraday chart for GE HealthCare Technologies Inc. +3.64% +4.90%
May. 05 GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science CI
May. 01 Mizuho Adjusts Price Target on GE HealthCare Technologies to $105 From $110 MT

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 26,546 35,199 37,024 - -
Enterprise Value (EV) 1 33,350 42,137 42,175 40,097 37,738
P/E ratio 14 x 25.4 x 20 x 17.6 x 15.7 x
Yield - - 0.09% 0.23% 0.3%
Capitalization / Revenue 1.45 x 1.8 x 1.83 x 1.75 x 1.66 x
EV / Revenue 1.82 x 2.16 x 2.09 x 1.89 x 1.69 x
EV / EBITDA 10.6 x 11.8 x 11.4 x 10 x 8.77 x
EV / FCF - 24.6 x 23 x 24.7 x 12.2 x
FCF Yield - 4.07% 4.36% 4.06% 8.22%
Price to Book - 4.94 x 4.2 x 3.46 x 2.89 x
Nbr of stocks (in thousands) 454,710 455,243 456,465 - -
Reference price 2 58.38 77.32 81.11 81.11 81.11
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 18,341 19,552 20,183 21,181 22,319
EBITDA 1 3,155 3,566 3,707 4,009 4,302
EBIT 1 2,522 2,956 3,144 3,437 3,765
Operating Margin 13.75% 15.12% 15.58% 16.23% 16.87%
Earnings before Tax (EBT) 1 2,512 2,361 2,568 2,895 3,217
Net income 1 1,916 1,568 1,857 2,121 2,360
Net margin 10.45% 8.02% 9.2% 10.01% 10.58%
EPS 2 4.180 3.040 4.055 4.608 5.172
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
FCF margin - 8.77% 9.1% 7.68% 13.9%
FCF Conversion (EBITDA) - 48.07% 49.56% 40.57% 72.13%
FCF Conversion (Net income) - 109.31% 98.92% 76.68% 131.46%
Dividend per Share 2 - - 0.0750 0.1897 0.2460
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,576 4,938 4,707 4,817 4,822 5,206 4,650 4,891 5,065 5,533 4,901 5,149
EBITDA 1 - - - - 808 981 749 893.6 962.3 1,096 910.4 -
EBIT 1 - 777 664 711 744 837 681 738.9 808.8 947 751.1 807.3
Operating Margin - 15.74% 14.11% 14.76% 15.43% 16.08% 14.65% 15.11% 15.97% 17.11% 15.32% 15.68%
Earnings before Tax (EBT) 1 - 718 546 570 636 609 512 587 671.3 800.3 603 660.7
Net income 1 487 554 189 418 375 403 374 424.1 479.3 581.4 462.8 491.7
Net margin 10.64% 11.22% 4.02% 8.68% 7.78% 7.74% 8.04% 8.67% 9.46% 10.51% 9.44% 9.55%
EPS 2 - 1.210 0.4100 0.9100 0.8200 0.8800 0.8100 0.9125 1.031 1.254 0.9825 1.067
Dividend per Share 2 - - - 0.0600 0.0300 - - - - 0.2106 - -
Announcement Date 11/7/22 1/30/23 4/25/23 7/25/23 10/31/23 2/6/24 4/30/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 6,804 6,938 5,151 3,073 714
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 2.157 x 1.946 x 1.39 x 0.7664 x 0.1659 x
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
ROE (net income / shareholders' equity) - 19% 24.7% 24.2% 22.6%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - 15.70 19.30 23.50 28.10
Cash Flow per Share 2 - 4.590 4.840 5.970 6.870
Capex 1 310 387 394 419 426
Capex / Sales 1.69% 1.98% 1.95% 1.98% 1.91%
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for GE HealthCare Technologies Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
81.11 USD
Average target price
93.71 USD
Spread / Average Target
+15.53%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+4.90% 37.02B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+7.87% 185B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+12.75% 135B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-1.37% 62.21B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.88% 51.01B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.59% 51.28B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+2.71% 41.85B
RESMED, INC. Stock ResMed, Inc.
+23.75% 31.27B
PHILIPS NV Stock Philips NV
+16.47% 23.66B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. GEHC Stock
  4. Financials GE HealthCare Technologies Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW